SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) PHARMALAB Share Price near 52-week high as stock trades at Rs 1,303

SYMBIOTEC Share Price is trading at Rs 1,303, up 3.72% today, and is positioned close to its 52-week high while the company’s market capitalisation stands at Rs 8,042.29 crore. The move keeps SYMBIOTEC Share Price in focus across SYMBIOTEC Share Price Today and SYMBIOTEC Stock News searches because the latest Univest data confirms a one-year high zone event, but does not establish any company-specific catalyst.

The latest Univest figures show SYMBIOTEC Share Price moving above the prior session’s level of Rs 1,256.25 after opening at Rs 1,246.05 and touching an intraday high of Rs 1,305.50. For readers tracking SYMBIOTEC Share Price Live, the price action places the stock in the near 52-week high category, which naturally lifts search interest around SYMBIOTEC Share Price Today, SYMBIOTEC Share News and SYMBIOTEC Share Price Update.

SYMBIOTEC Share Price Today: Price Action Analysis

At this stage, the verified data supports a simple reading: the stock is trading near its yearly high, the move is visible in the price print, and the company’s valuation metrics remain important to watch. Univest data also points to a stock that is being discussed in the context of SYMBIOTEC Fundamental Analysis, SYMBIOTEC Stock Analysis and broader SYMBIOTEC Latest News coverage.

Metric	Value
Current Price	Rs 1,303
Previous Close	Rs 1,256.25
Today's Move	+Rs 46.75 (+3.72%)
Open	Rs 1,246.05
High	Rs 1,305.5
Low	Rs 1,235
Market Capitalisation	Rs 8,042.29 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,303 versus the previous close of Rs 1,256.25, a rise of 3.72%. The stock opened at Rs 1,246.05, reached a high of Rs 1,305.5 and touched a low of Rs 1,235.

SYMBIOTEC Share Price Today shows a move from Rs 1,256.25 to Rs 1,303, a change of Rs 46.75 or 3.72%. The stock opened at Rs 1,246.05, traded between Rs 1,235 and Rs 1,305.50, and is therefore sitting very close to its 52-week high. The intraday range matters here because it shows where the stock is trading within the current market session, while the one-year high context explains why SYMBIOTEC Share Price is drawing attention in SYMBIOTEC Stock News.

Because the stock is near its 52-week peak, readers often search for SYMBIOTEC Share Price Today, SYMBIOTEC Share Price Live and SYMBIOTEC News Today together. The verified numbers confirm the price event, but they do not establish a company-specific reason behind it. That makes the current move a factual market update rather than a stated catalyst story.

For market watchers, the practical question is not whether SYMBIOTEC Share Price moved, but how the move fits into the broader context of its one-year high zone. Univest continues to track the stock’s price action and related market updates for readers following SYMBIOTEC Share Price Update and SYMBIOTEC Share News.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 8,042.29 crore
P/E Ratio	73.45x
P/B Ratio	5.38x
ROE	11.22%
ROCE	12.41%
EPS	Rs 17.1
Book Value Per Share	Rs 233.38
Dividend Yield	0%

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P/E 73.45x, P/B 5.38x, ROE 11.22%, ROCE 12.41%. These figures provide context only and are not a buy or sell signal.

SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 8,042.29 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 73.45x, P/B at 5.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 233.38, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.24x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	73.45x
Benchmark Median P/E	27.24x
Benchmark Average P/E	39.45x
Benchmark P/E Range	0x to 640x
Company P/B Ratio	5.38x
Benchmark Median P/B	2.81x
Company ROE	11.22%
Benchmark Median ROE	11.48%
Company ROCE	12.41%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 8,042.29 crore
Benchmark Median Market Cap	Rs 795.25 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 73.45x, which is above the benchmark median of 27.24x, a difference of +169.64%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.48%, a difference of -2.26%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.28%, a difference of -6.55%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

FAQPage JSON-LD

{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Why is SYMBIOTEC Share Price trending today?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price is trending because it is trading near its 52-week high at Rs 1,303, up 3.72% from the previous session. The market-cap reading of Rs 8,042.29 crore also keeps it in view."}},{"@type":"Question","name":"What is SYMBIOTEC Share Price today?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price today is Rs 1,303. It moved up from the previous close of Rs 1,256.25 and traded between Rs 1,235 and Rs 1,305.50 during the session."}},{"@type":"Question","name":"How close is SYMBIOTEC to its 52-week high?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price is very close to its 52-week high after touching Rs 1,305.50. That keeps SYMBIOTEC Stock News focused on the yearly high zone rather than a broad range move."}},{"@type":"Question","name":"What is SYMBIOTEC market capitalisation?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC market capitalisation is Rs 8,042.29 crore. This figure helps frame SYMBIOTEC Share Price against other listed healthcare and pharmaceuticals companies in the same industry benchmark."}},{"@type":"Question","name":"What is SYMBIOTEC P/E ratio?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price corresponds to a P/E ratio of 73.45. That is above the same-industry median of 27.24 and the average of 39.45 in the benchmark set."}},{"@type":"Question","name":"What is SYMBIOTEC P/B ratio?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price has a P/B ratio of 5.38. The same-industry median is 2.81 and the average is 4.16, so the stock trades above the benchmark on book value multiples."}},{"@type":"Question","name":"What do SYMBIOTEC ROE and ROCE show?","acceptedAnswer":{"@type":"Answer","text":"SYMBIOTEC Share Price is backed by ROE of 11.22% and ROCE of 12.41%. Both are close to the industry median, which provides useful context for SYMBIOTEC Fundamental Analysis."}},{"@type":"Question","name":"What is the latest SYMBIOTEC revenue figure?","acceptedAnswer":{"@type":"Answer","text":"The latest quarterly revenue shown for SYMBIOTEC is Rs 218.15 crore for Jun 2026. This helps readers compare SYMBIOTEC Share Price with the company’s reported business scale."}}]}

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Suven Life Sciences Ltd.	SUVEN	8,014.89	0	15.21	-101.8	-78.71
Aarti Pharmalabs Ltd.	AARTIPHARM	7,856.5	36.72	3.57	8.5	10.77
Sanofi Consumer Healthcare India Ltd.	SANOFICONR	8,267.76	31.08	23.76	73.2	98.11
Procter & Gamble Health Ltd.	PGHL	8,567.61	24.01	13.92	62.18	84.86
Bliss GVS Pharma Ltd.	BLISSGVS	7,029.51	51.24	5.66	12.11	17.4

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 73.45x compared with the displayed peer median of 31.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 8,042.29 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching SYMBIOTEC

• SYMBIOTEC Share Price is trading at Rs 1,303, up 3.72% from the previous session’s Rs 1,256.25.
• The stock is near its 52-week high after touching Rs 1,305.50 during the session.
• Market capitalisation stands at Rs 8,042.29 crore, which helps frame SYMBIOTEC Market Cap searches.
• P/E is 73.45 and P/B is 5.38, both above the same-industry median.
• ROE is 11.22% and ROCE is 12.41%, which give additional SYMBIOTEC Fundamental Analysis context.

About SYMBIOTEC

SYMBIOTEC PHARMALAB LTD operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following SYMBIOTEC Company News, this classification is the core business context available in the market record used by Univest. The company’s listed identity, sector and industry are the main descriptive anchors for SYMBIOTEC Share Price, SYMBIOTEC NSE and SYMBIOTEC BSE searches.

The current market view is therefore driven by the share price event, valuation multiples and peer context rather than by a longer business description. That makes SYMBIOTEC Share Price, SYMBIOTEC Stock Performance and SYMBIOTEC Latest News the most useful entry points for ongoing tracking on Univest.

Frequently Asked Questions

Why is SYMBIOTEC Share Price trending today?

Ans. SYMBIOTEC Share Price is trending because it is trading near its 52-week high at Rs 1,303, up 3.72% from the previous session. The market-cap reading of Rs 8,042.29 crore also keeps it in view.

What is SYMBIOTEC Share Price today?

Ans. SYMBIOTEC Share Price today is Rs 1,303. It moved up from the previous close of Rs 1,256.25 and traded between Rs 1,235 and Rs 1,305.50 during the session.

How close is SYMBIOTEC to its 52-week high?

Ans. SYMBIOTEC Share Price is very close to its 52-week high after touching Rs 1,305.50. That keeps SYMBIOTEC Stock News focused on the yearly high zone rather than a broad range move.

What is SYMBIOTEC market capitalisation?

Ans. SYMBIOTEC market capitalisation is Rs 8,042.29 crore. This figure helps frame SYMBIOTEC Share Price against other listed healthcare and pharmaceuticals companies in the same industry benchmark. The company operates in the Healthcare sector.

What is SYMBIOTEC P/E ratio?

Ans. SYMBIOTEC Share Price corresponds to a P/E ratio of 73.45. That is above the same-industry median of 27.24 and the average of 39.45 in the benchmark set. Its P/B ratio is 5.38x.

What is SYMBIOTEC P/B ratio?

Ans. SYMBIOTEC Share Price has a P/B ratio of 5.38. The same-industry median is 2.81 and the average is 4.16, so the stock trades above the benchmark on book value multiples.

What do SYMBIOTEC ROE and ROCE show?

Ans. SYMBIOTEC Share Price is backed by ROE of 11.22% and ROCE of 12.41%. Both are close to the industry median, which provides useful context for SYMBIOTEC Fundamental Analysis.

What is the latest SYMBIOTEC revenue figure?

Ans. The latest quarterly revenue shown for SYMBIOTEC is Rs 218.15 crore for Jun 2026. This helps readers compare SYMBIOTEC Share Price with the company’s reported business scale.

Track SYMBIOTEC Share Price on Univest

Use SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track SYMBIOTEC Share Price Live on Univest along with SYMBIOTEC Share Price Today, market cap, valuation ratios, sector comparison and the latest one-year high zone updates. Univest also helps users follow SYMBIOTEC Stock News, SYMBIOTEC Fundamental Analysis and SYMBIOTEC Share Price Update in one place.